| Anthony M Sparano, MD | |
|
2331 Highway 34, Blg 1 Suite 118, Manasquan, NJ 08736-1423 | |
| (732) 280-3223 | |
| (732) 280-2626 |
| Full Name | Anthony M Sparano |
|---|---|
| Gender | Male |
| Speciality | Otolaryngology |
| Experience | 22 Years |
| Location | 2331 Highway 34, Manasquan, New Jersey |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1992861850 | NPI | - | NPPES |
| Entity Name | Sparano Face And Nasal Institute |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1396047791 PECOS PAC ID: 1557540168 Enrollment ID: O20110128000515 |
News Archive
A new synthetic paper for finger-prick blood tests could provide accurate point-of-care diagnostics for cancer, COVID-19, and other serious diseases.
At the conclusion of the 59th session of the WHO Regional Committee for Africa, African health ministers agreed on four resolutions that aim to improve health on the continent, the Guardian reports.
A new survey by Cancer Research UK, released to launch their Man Alive Campaign, is suggesting that 25% of British men are "in denial" about their waist measurement, and most men, when questioned were unaware that being overweight, obese, or inactive, increases the risk of cancer.
ReVision Optics, a leading company in the research, development and manufacture of implantable medical devices designed to assist patients that need reading glasses, announced today that it has completed enrollment and initial follow up in Phase I of its US clinical trial and has filed for expansion. The clinical trial is for the study of the PresbyLens, recently renamed Vue+, for the improvement of near vision in patients with presbyopia, the age-related loss of near vision.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Anthony M Sparano, MD 2331 Highway 34, Manasquan, NJ 08736-1423 Ph: (732) 280-3223 | Anthony M Sparano, MD 2331 Highway 34, Blg 1 Suite 118, Manasquan, NJ 08736-1423 Ph: (732) 280-3223 |
News Archive
A new synthetic paper for finger-prick blood tests could provide accurate point-of-care diagnostics for cancer, COVID-19, and other serious diseases.
At the conclusion of the 59th session of the WHO Regional Committee for Africa, African health ministers agreed on four resolutions that aim to improve health on the continent, the Guardian reports.
A new survey by Cancer Research UK, released to launch their Man Alive Campaign, is suggesting that 25% of British men are "in denial" about their waist measurement, and most men, when questioned were unaware that being overweight, obese, or inactive, increases the risk of cancer.
ReVision Optics, a leading company in the research, development and manufacture of implantable medical devices designed to assist patients that need reading glasses, announced today that it has completed enrollment and initial follow up in Phase I of its US clinical trial and has filed for expansion. The clinical trial is for the study of the PresbyLens, recently renamed Vue+, for the improvement of near vision in patients with presbyopia, the age-related loss of near vision.
› Verified 8 days ago
Mitchell Josef Faktor, Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 2528 River Rd, Manasquan, NJ 08736 Phone: 732-223-7444 | |
Ronald Joseph Iannacone, DO Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 2640 Highway 70, Bldg 6b, Manasquan, NJ 08736 Phone: 732-223-8686 Fax: 732-223-6572 |